Immunotherapy
News and reporting on cancer immunotherapy.
Pionyr Immunotherapeutics, Abcam Exploring Potential CDx for Anti-TREM2 Therapy
The drugmaker will assess Abcam's anti-TREM2 antibody as a diagnostic tool to identify patients with TREM2-expressing macrophages in tumor samples.
Lifileucel's BLA is again delayed, but a 33-month update from a pivotal melanoma trial, along with early data from a frontline study, show continued potential.
Oncocyte, Italian Foundation to Investigate DetermaIO in Colorectal Cancer
The Italian research group will evaluate the ability of Oncocyte's gene expression assay in samples from immunotherapy trials for advanced colorectal cancer patients.
Biodesix, Addario Lung Cancer Institute Enroll First Patient in NSCLC Biomarker Study
Through the BEACON-Lung study, investigators will use Biodesix's serum-based test to identify predictive biomarkers of immunotherapy response beyond PD-L1.
Kiromic Submits IND to FDA for Allogeneic T-cell Therapy
The IND is for a Phase I trial of its PD-1, gamma-delta switch receptor therapy, which the firm believes will accelerate the immune system's response against PD-L1-positive tumors.